AqVida develops, produces and distributes high-quality, generic oncology medications. As a reliable partner, the company offers innovative therapies and the highest quality standards - for a secure supply worldwide.
Sign up for free.
AqVida GmbH is a leading pharmaceutical company from Northern Germany, specializing in the development, registration, manufacturing, and distribution of generic oncology medications.[1][3][4] Founded in 2005 in Hamburg, AqVida has developed into a reliable partner for oncologists, pharmacies, and patients worldwide, with high-quality products that are in international demand.[1][4]
The portfolio includes the most important generics for treating the most common types of cancer, including Carboplatin AqVida (10 mg/ml concentrate for solution for injection in fill volumes of 50 mg/10 ml, 100 mg/20 ml and 200 mg/40 ml) as well as Oxaliplatin AqVida (5 mg/ml concentrate for solution for infusion).[2][9] AqVida offers a complete service package for partners: from product development to registration to manufacturing and distribution.[6] The modern production facility in Northwest Mecklenburg (Dassow), opened in 2016, uses OEB-5 cleanroom conditions and isolator technology to safely fill highly toxic concentrates and even Antibody-Drug-Conjugates (ADCs).[1][6][7] This ensures a short, secure supply chain and maximum security of supply.[3][6]
The core mission of AqVida is: 100% Quality in all processes, products and services – without compromise.[4][6] The company stands personally by its partners and reacts flexibly to urgent needs in order to make medications available at short notice.[4] Quality management meets the strictest standards: EU-GMP and US-FDA.[1][3] AqVida supports doctors in providing patients with the best possible therapy and relieves those affected of concerns about medication quality.[5] As "Quality made in Germany", the company exports from Mecklenburg-Vorpommern worldwide and has established itself as a Major Player in generic oncology.[1][4][10]
AqVida emphasizes sustainable security of supply through its highly technical, flexible production in Germany, which shortens supply chains and minimizes dependencies – a contribution to the resilience of the global healthcare system.[1][3][6] The focus on German manufacturing reduces CO₂ footprints through short transport routes, and the strict quality standards ensure long-lasting, safe products. In addition, AqVida actively warns against counterfeiting, such as with Oxaliplatin, to protect patient safety.[2] Current initiatives include expanding production for common cancer medications to avoid bottlenecks.[10]
AqVida combines innovation, reliability and excellence to make oncology therapies accessible and safe. With a focus on quality and flexibility, the company remains a strong partner in the fight against cancer.[4][5]
(Total length: approx. 2480 characters incl. spaces)
